| GO ID | GO name | Interaction type | Reference |
|---|---|---|---|
| GO:0002115 | Store-operated calcium entry | Increases phenotype | PMID:24990931; PMID:8759727 |
| GO:0003994 | Aconitate hydratase activity | Decreases phenotype | PMID:39477182 |
| GO:0004197 | Cysteine-type endopeptidase activity | Increases phenotype | PMID:23741617; PMID:26513129 |
| GO:0006094 | Gluconeogenesis | Increases phenotype | PMID:28223344 |
| GO:0006309 | Apoptotic dna fragmentation | Increases phenotype | PMID:12198651; PMID:16357177; PMID:9541492 |
| GO:0006412 | Translation | Decreases phenotype | PMID:23741617 |
| GO:0006641 | Triglyceride metabolic process | Affects phenotype | PMID:34516972 |
| GO:0006749 | Glutathione metabolic process | Affects phenotype | PMID:39477182 |
| GO:0006811 | Monoatomic ion transport | Increases phenotype | PMID:11788349; PMID:7691410 |
| GO:0006874 | Cellular calcium ion homeostasis | Affects phenotype | PMID:11914123; PMID:25371527; PMID:26363153; PMID:26398720; PMID:26677073; PMID:27640744; PMID:27640744; PMID:37920924; PMID:28823644; PMID:29248592; PMID:31054997; PMID:31467635; PMID:32314600; PMID:33906515; PMID:37920924; PMID:39153536 |
| GO:0006915 | Apoptotic process | Increases phenotype | PMID:10946849; PMID:12606818; PMID:12871656; PMID:12871656; PMID:16153637; PMID:15039469; PMID:15488331; PMID:16338971; PMID:18477628; PMID:18669601; PMID:20022965; PMID:20130848; PMID:20493918; PMID:20626587; PMID:26677073; PMID:37741535; PMID:39477182; PMID:9541492 |
| GO:0006974 | Cellular response to dna damage stimulus | Increases phenotype | PMID:32574669 |
| GO:0006979 | Response to oxidative stress | Increases phenotype | PMID:20493918 |
| GO:0007005 | Mitochondrion organization | Affects phenotype | PMID:39477182 |
| GO:0007033 | Vacuole organization | Increases phenotype | PMID:24898257 |
| GO:0007049 | Cell cycle | Increases phenotype | PMID:11754638 |
| GO:0007204 | Positive regulation of cytosolic calcium ion concentration | Increases phenotype | PMID:19467708; PMID:25455450; PMID:26264395; PMID:26769196; PMID:27226631; PMID:27939335; PMID:8759727 |
| GO:0007268 | Chemical synaptic transmission | Increases phenotype | PMID:15857686 |
| GO:0008219 | Cell death | Increases phenotype | PMID:16388830; PMID:25762722; PMID:28025169; PMID:29453283 |
| GO:0008283 | Cell population proliferation | Decreases phenotype | PMID:24892553; PMID:24898257; PMID:28161410; PMID:29453283 |
| GO:0008284 | Positive regulation of cell population proliferation | Increases phenotype | PMID:23544152 |
| GO:0008285 | Negative regulation of cell population proliferation | Increases phenotype | PMID:30841431 |
| GO:0008610 | Lipid biosynthetic process | Affects phenotype | PMID:32535746 |
| GO:0009395 | Phospholipid catabolic process | Increases phenotype | PMID:23041292 |
| GO:0010729 | Positive regulation of hydrogen peroxide biosynthetic process | Increases phenotype | PMID:19467708 |
| GO:0010890 | Positive regulation of sequestering of triglyceride | Increases phenotype | PMID:29414781 |
| GO:0010942 | Positive regulation of cell death | Increases phenotype | PMID:26124276; PMID:29793971 |
| GO:0016049 | Cell growth | Decreases phenotype | PMID:30243730; PMID:30508555 |
| GO:0016477 | Cell migration | Increases phenotype | PMID:24898257 |
| GO:0018158 | Protein oxidation | Increases phenotype | PMID:39477182 |
| GO:0019395 | Fatty acid oxidation | Increases phenotype | PMID:32535746 |
| GO:0019722 | Calcium-mediated signaling | Increases phenotype | PMID:10797495; PMID:12198651; PMID:12632256; PMID:15006548; PMID:15236632; PMID:15236632; PMID:15350831; PMID:15350831; PMID:15379781; PMID:17917717; PMID:19448140; PMID:20130848; PMID:21350800 |
| GO:0030199 | Collagen fibril organization | Increases phenotype | PMID:39477182 |
| GO:0030262 | Apoptotic nuclear changes | Increases phenotype | PMID:26124276 |
| GO:0030335 | Positive regulation of cell migration | Increases phenotype | PMID:23544152 |
| GO:0030968 | Endoplasmic reticulum unfolded protein response | Increases phenotype | PMID:23123503 |
| GO:0032057 | Negative regulation of translational initiation in response to stress | Increases phenotype | PMID:25268112 |
| GO:0032469 | Endoplasmic reticulum calcium ion homeostasis | Affects phenotype | PMID:25418486 |
| GO:0032471 | Negative regulation of endoplasmic reticulum calcium ion concentration | Increases phenotype | PMID:26085089 |
| GO:0034063 | Stress granule assembly | Affects phenotype | PMID:29576526 |
| GO:0034440 | Lipid oxidation | Increases phenotype | PMID:39477182 |
| GO:0034976 | Response to endoplasmic reticulum stress | Increases phenotype | PMID:20477944; PMID:24865413 |
| GO:0035752 | Lysosomal lumen ph elevation | Increases phenotype | PMID:34516972 |
| GO:0036483 | Neuron intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress | Increases phenotype | PMID:26264395 |
| GO:0036494 | Positive regulation of translation initiation in response to endoplasmic reticulum stress | Increases phenotype | PMID:16330322 |
| GO:0042307 | Positive regulation of protein import into nucleus | Increases phenotype | PMID:27587023 |
| GO:0042310 | Vasoconstriction | Decreases phenotype | PMID:23177664 |
| GO:0042554 | Superoxide anion generation | Affects phenotype | PMID:35544339 |
| GO:0043065 | Positive regulation of apoptotic process | Increases phenotype | PMID:20477944; PMID:25341683; PMID:30215789; PMID:30841431 |
| GO:0043303 | Mast cell degranulation | Increases phenotype | PMID:27018130 |
| GO:0043525 | Positive regulation of neuron apoptotic process | Increases phenotype | PMID:35028790 |
| GO:0044237 | Cellular metabolic process | Decreases phenotype | PMID:26513129; PMID:27748814; PMID:35544339; PMID:37920924 |
| GO:0045907 | Positive regulation of vasoconstriction | Increases phenotype | PMID:11964372 |
| GO:0046034 | Atp metabolic process | Affects phenotype | PMID:35544339 |
| GO:0046460 | Neutral lipid biosynthetic process | Increases phenotype | PMID:32535746 |
| GO:0050731 | Positive regulation of peptidyl-tyrosine phosphorylation | Increases phenotype | PMID:8759727 |
| GO:0050900 | Leukocyte migration | Decreases phenotype | PMID:23539630 |
| GO:0051281 | Positive regulation of release of sequestered calcium ion into cytosol | Increases phenotype | PMID:23885834; PMID:24990931; PMID:26085089; PMID:26341291; PMID:29630867; PMID:8759727 |
| GO:0051480 | Regulation of cytosolic calcium ion concentration | Affects phenotype | PMID:11964372 |
| GO:0051881 | Regulation of mitochondrial membrane potential | Decreases phenotype | PMID:16153637; PMID:16388830; PMID:20493918; PMID:26677073; PMID:39477182 |
| GO:0055074 | Calcium ion homeostasis | Affects phenotype | PMID:23530660; PMID:27060209; PMID:28347754; PMID:29883672; PMID:30056177; PMID:30243730; PMID:31709706 |
| GO:0060012 | Synaptic transmission, glycinergic | Affects phenotype | PMID:30439410 |
| GO:0060402 | Calcium ion transport into cytosol | Increases phenotype | PMID:27709270 |
| GO:0061909 | Autophagosome-lysosome fusion | Decreases phenotype | PMID:31862506 |
| GO:0062029 | Positive regulation of stress granule assembly | Increases phenotype | PMID:27030674 |
| GO:0070509 | Calcium ion import | Increases phenotype | PMID:30394170 |
| GO:0070886 | Positive regulation of calcineurin-nfat signaling cascade | Increases phenotype | PMID:24990931 |
| GO:0071421 | Manganese ion transmembrane transport | Increases phenotype | PMID:8759727 |
| GO:0072593 | Reactive oxygen species metabolic process | Affects phenotype | PMID:35544339 |
| GO:0075522 | Ires-dependent viral translational initiation | Decreases phenotype | PMID:25268112 |
| GO:0086003 | Cardiac muscle cell contraction | Affects phenotype | PMID:39477182 |
| GO:0090398 | Cellular senescence | Affects phenotype | PMID:24898257 |
| GO:0097352 | Autophagosome maturation | Decreases phenotype | PMID:28347754 |
| GO:0098609 | Cell-cell adhesion | Increases phenotype | PMID:28025169 |
| GO:1900103 | Positive regulation of endoplasmic reticulum unfolded protein response | Increases phenotype | PMID:32407927 |
| GO:1901341 | Positive regulation of store-operated calcium channel activity | Increases phenotype | PMID:19467708 |
| GO:1901896 | Positive regulation of atpase-coupled calcium transmembrane transporter activity | Increases phenotype | PMID:7673132 |
| GO:1902108 | Regulation of mitochondrial membrane permeability involved in apoptotic process | Affects phenotype | PMID:39477182 |
| GO:1902512 | Positive regulation of apoptotic dna fragmentation | Increases phenotype | PMID:23885834 |
| GO:1903409 | Reactive oxygen species biosynthetic process | Increases phenotype | PMID:28347754 |
| GO:1903675 | Negative regulation of cap-dependent translational initiation | Increases phenotype | PMID:25268112 |
| GO:1903896 | Positive regulation of ire1-mediated unfolded protein response | Increases phenotype | PMID:29414781 |
| GO:1903899 | Positive regulation of perk-mediated unfolded protein response | Increases phenotype | PMID:27638049 |
| GO:1905665 | Positive regulation of calcium ion import across plasma membrane | Increases phenotype | PMID:29476780 |
| GO:1905692 | Endoplasmic reticulum disassembly | Increases phenotype | PMID:37741535 |
| GO:1905898 | Positive regulation of response to endoplasmic reticulum stress | Increases phenotype | PMID:35028790 |
| GO:2000676 | Positive regulation of type b pancreatic cell apoptotic process | Increases phenotype | PMID:34588186 |
| GO:2001214 | Positive regulation of vasculogenesis | Increases phenotype | PMID:23544152 |
We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.